We investigated the molecular epidemiology of carbapenem-resistant Acinetobacter baumannii from a Taiwanese hospital and determined the mechanisms responsible for resistance.
Introduction
Carbapenem-resistant Acinetobacter spp. have been increasingly reported worldwide, 1 raising serious concerns about the limited antimicrobial treatment options remaining. 2 The most prevalent mechanism of carbapenem resistance is the production of class D (OXA) carbapenemases, 2 including both acquired types (OXA-23-, OXA-24-and OXA-58-like) and ISAba1-enhanced expression of the intrinsic chromosomal bla OXA-51-like gene of Acinetobacter baumannii. 3 Less common is the production of class B metallo-b-lactamases (MBLs) while, on a few occasions, resistance has been associated with altered penicillin-binding proteins, 4 loss of outer membrane proteins (OMPs) 5, 6 and other b-lactamases. 7 In particular, loss of CarO OMP, which forms non-specific monomeric porin channels, 8 is reported to cause carbapenem resistance in A. baumannii, 9 though the prevalence of this mechanism has not been reported; combinations of resistance mechanisms have been observed too, 10 -13 though, again, the role of CarO loss is unclear in this context.
There are marked geographic differences in the prevalence of these mechanisms of carbapenem resistance, with wide variability also reported in the transmissibility of acquired OXA and metallo-carbapenemases, and in the clonality of resistant isolates. 14 -19 Better understanding of these aspects is required to optimize both infection control and treatment. Here we studied the molecular epidemiology and mechanisms of carbapenem resistance in A. baumannii in a Taiwanese hospital, with emphasis on the role of carbapenemases and the loss of CarO OMP.
Materials and methods

Isolates and susceptibility testing
From January 2005 to June 2007, all Acinetobacter spp. isolates with meropenem resistance by the CLSI disc method 20 were collected from a 500 bed hospital in Taiwan. Identification of A. baumannii was confirmed by recA amplification and sequencing. 21 Multiple isolates from a single patient with the same antibiogram and molecular characteristics were counted as one isolate. MICs were determined subsequently by agar dilution methodology following BSAC guidelines. 22 
PCR amplification and sequencing
Multiplex PCRs were used to detect genes encoding OXA and metallo-carbapenemases. 23, 24 ISAba1, which can act as a promoter for bla OXA-51-like , bla OXA-23-like and ampC genes, was sought with primers ISAba1F and ISAba1R; 25 its linkage upstream of the bla OXA-51-like gene was sought with primers ISAba1F and OXA-51-likeR. 3 PCR and sequencing of the carO gene used primers 5
0 -CAT ATG AAA GTA TTA CGT GTT TTA GTG-3 0 and 5 0 -GGT ACC TTA CCA GTA GAA GTT TAC ACC-3 0 ; 9 the carO promoter region was amplified with primers 5 0 -AAC GTG TTA CGT TTA ATT GAG GTA T-3 0 and 5 0 -TTT TCT CCT TAA GAA AAG GCT CTG-3 0 . The PCR conditions for carO amplification were: initial denaturation at 948C for 1 min; 10 cycles of denaturation at 948C for 20 s, primer annealing at 528C for 10 s and primer extension at 688C for 150 s; and 25 cycles of denaturation at 948C for 20 s, primer annealing at 588C for 10 s and primer extension at 688C for 150 s. ampC was sought with primers ACI5 and ACI6, 15 while primers preABpromþ and preAB2 26 were used to seek any upstream copy of ISAba1. Whether known Acinetobacter IS elements immediately preceded bla OXA-24-like and bla OXA-23-like genes was sought using an IS-located forward primer-one of ISAba1B, ISAba2A, ISAba3C (tnpA of ISAba3-like and ISAba3), IS18B 27 or ISAba4A
28
-and a reverse primer located in the bla OXA gene. 24 Further characterization of the genetic structure surrounding bla OXA-58-like genes was undertaken using previously described primers. 27 Primers P1 and P2 were used to ascertain whether bla OXA-24 -related genes had flanking regions similar to those reported previously. 10 Sequencing of selected PCR products was performed with the primers used for amplification. In all cases, products were first purified with the Geneclean w Turbo for PCR Kit (Q-BIOgene, Cambridge, UK). In general, sequencing was performed using dye terminator chemistry on a CEQ8000 Genetic Analyzer (Beckman Coulter, High Wycombe, UK), with sequencing of bla OXA-24-like PCR products according to previously reported methods. 29 We also sequenced the carO gene when the PCR product was not of the expected size (741 bp).
Hybridization of plasmid and genomic DNA
Plasmid DNA was extracted from clinical isolates as described by Kado and Liu 30 or with a High Purity Plasmid Miniprep Kit (Marligen Biosciences, Inc., Ijamsville, MD, USA). After electrophoresis, the DNA was transferred to Hybond Nþ nylon membranes (Amersham, Little Chalfont, UK). Genomic DNA was prepared with bacterial cells embedded in low-melting-point gel and treated with lysozyme and protease K 31, 32 and then restricted with I-CeuI enzyme, which is a double-strand endonuclease yielding seven fragments that were separated on a CHEF-DR II apparatus (Bio-Rad, Hemel Hempstead, UK) 31, 33 and transferred to nylon membranes.
Digoxigenin-11-dUTP (Roche, Lewes, UK) was used to produce labelled probes by PCR with OXA-24-like primers 24 and 16S rRNA primers. 34 Labelling of probes and hybridization to blots of plasmid or I-CeuI-digested genomic DNA were performed as previously reported. 35 Plasmids were sized by comparison with those of Escherichia coli strain V517 (NCTC 50193).
OMP analysis
The OMPs of selected clinical isolates were analysed by SDS-PAGE using 12.5% gels. 36 A. baumannii ATCC 19606 was used as a positive control for CarO expression.
PFGE
DNA fingerprinting was done by PFGE of ApaI-digested genomic DNA 32 with banding patterns analysed using BioNumerics software (BioNumerics, Sint-Martens-Latem, Belgium). Isolates were considered to be of the same pulsotype if there was .85% similarity.
Statistical analysis
Categorical variables were evaluated using the Pearson x 2 test or Fisher's exact test where more appropriate. The threshold for a significant difference was designated at P,0.05.
Results
Characterization of A. baumannii isolates
According to local disc susceptibility testing results, 111 of 396 (28%) Acinetobacter spp. isolated in the hospital during the 30 month study period were resistant to meropenem. After exclusion of those isolates that were duplicates from particular patients, had meropenem MICs ,16 mg/L or were Acinetobacter genomic species 3, 92 A. baumannii isolates were included: 47 from ventilated patients in the respiratory care unit, 29 from intensive care unit patients and 16 from patients on general wards. Fifty-three (57.6%) isolates caused infection and 39 were considered to be colonization isolates.
Three major PFGE types accounted for 70 (76%) of the 92 isolates ( Figure 1 ): pulsotype I (23 isolates), II (16 isolates) and III (31 isolates). The remaining 22 isolates belonged to eight pulsotypes. The temporal distribution of the three major pulsotypes is shown in Figure 2 gene, which was confirmed by sequencing from seven isolates (six from three major pulsotypes and one from a minor pulsotype) to encode OXA-72 carbapenemase (GenBank accession no. AY739646); only 29 of these yielded products with primer pair P1/P2, indicating that the flanking sequences differed significantly in the remaining 30 isolates from those published previously. 10 The 59 OXA-72 enzyme producers included 17 of 23 pulsotype I isolates, 28 of 31 pulsotype III isolates and 14 of 22 isolates of minor pulsotypes (Table 2) ; those not giving a P1/P2 product were distributed among multiple pulsotypes (Figure 1) . The bla OXA-72 gene was not detected in pulsotype II isolates, all of which had ISAba1 before the bla OXA-51-like gene. Only four (6.8%) OXA-72 producers also had ISAba1 before bla OXA-51-like genes ( Table 2) .
Genes encoding two other acquired carbapenemases (bla OXA-58-like and bla OXA-23-like ) were detected. Two isolates of the same minor pulsotype (i.e. not belonging to pulsotypes I, II or III) had a bla OXA-58-like gene. These gave positive PCR results using: (i) forward primers ISAba3C and ISAba2A 27 with a bla OXA-58-like reverse primer and (ii) the bla OXA-58-like forward primer with ISAba3B, indicating the same genetic structure as found in A. baumannii MAD, 27 with ISAba3-like and ISAba2 elements upstream of bla OXA-58-like and an ISAba3 element downstream of it. One further isolate had bla OXA-23-like . None of these three isolates had ISAba1 preceding the bla OXA-51-like gene, but ISAba1 was located immediately upstream of the bla OXA-23-like gene.
None of the 92 isolates had any of the five MBL genes sought; all had an ampC gene and only one isolate lacked ISAba1 before ampC.
The levels of imipenem and meropenem resistance associated with the two predominant resistance mechanisms differed. Production of OXA-72 carbapenemase was more often associated (56 of 59 isolates) with high-level imipenem resistance (MICs 32 mg/L) than was ISAba1-enhanced expression of a bla OXA-51-like gene (3 of 29 isolates; P, 0.001).
Plasmid location of bla Plasmid DNA from two isolates, skb94 and skb109, was hybridized with a bla OXA-72 probe and revealed bla OXA-72 to be located on a plasmid of 54 kb. The 54 kb plasmid was found in one pulsotype I isolate, one pulsotype III isolate and in two isolates of minor pulsotypes that were randomly selected for plasmid profile experiments. Attempts to transfer this plasmid by conjugation or transformation were unsuccessful. The lack of hybridization of these plasmid preparations with a 16S rRNA probe excluded the possibility that hybridization with the bla OXA-72 probe was contingent on contaminating chromosomal DNA in the plasmid extract; moreover, the OXA-24-like probe did not hybridize with any I-CeuI-restricted chromosomal fragment.
Loss of CarO OMP
All isolates yielded a carO PCR product, but five gave an amplicon of 1900 bp rather than the expected size of 750 bp; two of these were of pulsotype I and three were of pulsotype III; all were OXA-72 carbapenemase producers. In each of these five cases, the carO sequence was identical to GenBank accession no. EF646275, but was disrupted by the insertion of a divergently transcribed ISAba1 element, which was flanked by direct repeats of CAACGTTTA ( 
Discussion
The OXA-24-like carbapenemases comprise OXA-40 (which is synonymous with OXA-24), OXA-25, OXA-26 and OXA-72 enzymes. 38 OXA-72 was first reported from an Acinetobacter strain from Thailand in 2004 (GenBank accession no. AY739646), and has since been reported in a single A. baumannii isolate found during a surveillance study in mainland China. 39 We have identified OXA-72 enzyme as the major mechanism of carbapenem resistance in A. baumannii in a hospital in Taiwan. OXA-72 enzyme-producing isolates were more resistant to carbapenems than those with ISAba1-enhanced expression of the intrinsic OXA-51-like enzyme. There were three concomitant outbreaks in the same hospital, involving three different Acinetobacter clones. The prevalence of OXA-72 enzyme in this hospital is in marked contrast to previous studies in Taiwan, which identified plasmid-borne OXA-58-like carbapenemase, 40 ISAba1-enhanced expression of intrinsic OXA-51-like carbapenemase, 13, 41 endemic spread of IMP-1 metallo-carbapenemase, 42 and spread of VIM-2, VIM-3, VIM-11 and IMP-8 metallo-carbapenemases 43 as carbapenem resistance mechanisms in Acinetobacter spp. It also differs from the situation in mainland China, where OXA-23 carbapenemase is prevalent, being detected in 97.7% of 221 imipenemresistant Acinetobacter isolates from one study. 39 The bla OXA-24-like genes of A. baumannii have previously been reported on the chromosome, 17, 33 on plasmids 18 or, in some isolates, in both locations. 16 In our isolates, bla OXA-72 was located on a 54 kb plasmid. In 29 of 59, it was flanked by sequences similar to those previously described, 10, 18 while in other isolates, the negative PCR result with P1/P2 primers suggested different genetic organization(s). Despite this variation, the presence of the bla OXA-72 gene in isolates of diverse pulsotypes, including major types I and III, indicates that both horizontal transfer and clonal spread played roles in the spread of this resistance mechanism in the hospital.
Multiple copies of ISAba1 are present in most isolates of Acinetobacter spp., but this element has not been found in Enterobacteriaceae or Pseudomonas aeruginosa. 25 It serves an important role as a 'mobile promoter'. 44 As evidence of this role, we found ISAba1 immediately upstream of bla AmpC and bla OXA-51-like genes in many of our isolates and, in the single OXA-23 carbapenemase producer, also before the bla OXA-23-like gene. It underlines further the role of ISAba1 as a key genetic element regarding the overall genetic plasticity of A. baumannii and its consequences on expression of resistance. As with other IS elements, ISAba1 can also cause insertional inactivation. Here we showed it to disrupt expression of CarO, an OMP that forms a non-specific monomeric channel that allows influx of carbapenems and is essential for L-ornithine uptake. 45 Similar disruption of this pore's expression, mediated by ISAba125 and ISAba825 elements, has been reported previously as the sole mechanism of carbapenem resistance in Acinetobacter isolates. 9, 17 ISAba1 insertion in the carO gene was detected in 5.4% of our A. baumannii isolates. Moreover, the prevalence of this resistance mechanism was probably underestimated since our PCR-based strategy was only able to identify carO genes of abnormal length, not those with promoter mutations or those encoding proteins with structural mutations. Combinations of resistance mechanisms, such as carbapenemases together with decreased porin expression, may act additively to confer high-level carbapenem resistance in A. baumannii. 11 -13,38,46,47 Isolates without CarO protein were reported to have MICs of imipenem of 16 mg/L. 9 However, most OXA-72-producing isolates had MICs of imipenem of more than 32 mg/L. The loss of CarO porin in isolates also producing OXA-72 carbapenemase does not produce a higher MIC value.
All of our isolates were susceptible to colistin, whereas non-susceptibility to tigecycline was seen in 51%. In view of this non-susceptibility rate and the low serum concentration attained, 48 it is essential to check susceptibility when considering tigecycline for treatment of infections caused by carbapenemresistant A. baumannii.
From the literature, it is clear that different hospitals experience different epidemiologies of carbapenem-resistant A. baumannii. The situation described here is unique in being the first where the OXA-72 variant of OXA-40 carbapenemase was the enzyme in outbreak strains and one of the few where plasmid transfer among strains was so important. 
